Latest Articles

Pathophysiology of Bullous Pemphigoid

In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Act Now for your ACS Patients

Meet a Sanofi Specialist

cGVHD Burden

Unmet Need

Rezurock Dosage

Rezurock Efficacy

Rezurock Safety